Miguel Regueiro, MD

Cleveland Clinic

Poster(s):

• P3252 - Mirikizumab Crohn's Disease VIVID-1 Study Placebo Response Differences Between the United States Labeling and Primary Manuscript Due to Methodological Differences in Handling Participants Randomized to Placebo
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT